BioCentury
ARTICLE | Company News

ElexoPharm, Merck deal

May 24, 2010 7:00 AM UTC

ElexoPharm and Merck partnered to develop candidates targeting aldosterone synthase ( ALDOS; CYP11B2) to treat cardiovascular disease. Merck is responsible for all development, regulatory filings, m...